# Radiotherapy to All Residual Lesions After Chemoimmunotherapy

> **NCT06479473** · PHASE1,PHASE2 · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Extensive-stage Small Cell Lung Cancer

## Interventions

- **RADIATION:** Radiotherapy to all residual lesions
- **DRUG:** Chemoimmunotherapy

## Key facts

- **NCT ID:** NCT06479473
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06479473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06479473, "Radiotherapy to All Residual Lesions After Chemoimmunotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06479473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*